Patients

Germany’s Cannabis Act (CanG) is beginning to transform the country's medical cannabis market, with potential opportunities to expand telemedicine, improve physician training, and enhancing accessibility in this rapidly growing industry.

The patient-centered organization announced its 2025 plans for medical cannabis at the national level.

Aspergillus, a genus of mold that is abundant in our environment, has become a significant concern in the cannabis industry, particularly due to the health risks it poses to consumers. This mold, which thrives in various environments, including soil, decaying vegetation, and even in the air, is not inherently dangerous to healthy individuals. However, its presence in cannabis flowers, whether during cultivation, processing, or storage, can lead to severe health risks, especially for immunocompromised individuals.

The researchers point out that it is important for clinicians to ask about CBD use to better advise patients and prevent potential drug interactions.

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

The study surveyed cannabis patients across the country on their use and perceptions of cannabis use during cancer treatment.

As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.

Americans for Safe Access, a medical cannabis patient advocacy organization, held a briefing on the final day of the comment period for the proposed rulemaking on cannabis.

In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.

Americans for Safe Access, the nation’s largest member-based medical cannabis advocacy organization, held a webinar discussing the recent recommendation made by the Department of Health and Human Services to reschedule cannabis.

Don't miss these exciting speakers in the medical and psychedelics tracks at Cannabis Science Conference Fall taking place September 21-22, 2023 in Providence, Rhode Island!

Filmed onsite at Cannabis Science Conference Spring 2023, Kim Stuck, founder and CEO of Allay Consulting, shares her unique insights and experiences in the industry.

Hear what the business director of a cannabis testing facility has to say about the future of the cannabis industry!

This article features real-life stories from a cannabis patient as well as an on-the-ground cannabis nurse.

A United Kingdom study revealed an association between cannabis products, improved quality of life, and reduced opioid use in chronic pain patients.

Our sister publication, Oncology Nursing News recently published how cannabidiol oil may be useful in helping patients with breast cancer manage tamoxifen-related adverse effects.

Two Colorado-based hemp companies and one tobacco company are joining forces to pursue FDA-approval for a new botanical drug.

A Washington State House Committee recently amended and then approved a psilocybin bill which will benefit patients.

Senate Bill 47, legalizing medical cannabis, was signed into law in March 2023 by Kentucky Governor Andy Beshear (D).

A pharmaceutical company, Vantage Hemp Co., announced it recently submitted two Drug Master Files (DMFs) to the Food and Drug Administration.

A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.

In March 2023, Texas lawmakers approved of House Bill 1085.

Physician and cannabis expert, Dr. Peter Grinspoon, has released his new book titled,”Seeing through the Smoke.” In this informative piece of literature, Dr. Grinspoon discusses separating fact from fiction, cannabis research, and a guide on how to use cannabis safely.

Cannabis Patient Care published a wide variety of content throughout 2022—here is just a small snippet of some of the top articles and columns that our readers enjoyed. Click through and see if any of your favorites made the list!

The Food and Drug Administration (FDA) will hold an educational webinar on cannabis and cannabis-derived products for healthcare practitioners in late March.

A pioneer in global cannabis research, Professor Raphael Mechoulam died March 9th, 2023 in Israel at the age of 92.

In December 2022, hospital staff in Hays, Kansas reported a terminally ill cancer patient to police for use of a cannabis vape pen.

Steve Ellmore, founder of The Unprescribed nonprofit, is a 20-year Air Force veteran. Here, Ellmore shares how his personal experience led him to become a medical cannabis patient and how his award-winning 2020 film, Unprescribed, documents the stories of veterans, cannabis advocacy, and the fight to end veteran suicide.

Recently, the Cannabis Nurses Network held their 2022 nurse appreciation celebration virtually. Events included an expo hall, a year in review, educational sessions and networking, and the awards ceremony.

Due to inflation and rising costs of living, Leaf411 resumed its affordability program to address the needs of patients seeking medical cannabis.